Ovarian Carcinoma — Trials

Ovarian Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

895 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 270
Recruiting: 140
Ph III recruiting: 16
Growth YoY: +23.1%
Industry share: 31%
Top sponsor: National Cancer Institute (NCI)
Termination share: 38.7%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (145)

clinicaltrialsPublishedShowing 51–55 of 55 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00039091	Monoclonal Antibody Therapy in Treating Patients With Ovarian Epithelial Cancer, Melanoma, Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Non-Small Cell Lung Cancer	terminated	Phase 1	26	National Cancer Institute (NCI)NIH	1	Sep 5, 2018	clinicaltrials
NCT02708511	Copper Cu 64-DOTA-B-Fab PET/CT in Imaging Patients With Ovarian and Breast Cancer	terminated	Phase 1	2	Sanjiv Sam GambhirOTHER	1	Apr 5, 2018	clinicaltrials